BYETTA

Exenatide · AstraZeneca Pharmaceuticals LP

Drug timelines are a Plus or Pro feature.

54 regulatory and trial events tracked for BYETTA, covering 2006-10-12 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes